Updating results…
What is Trilogy 100?
NIPPV, also known as Bilevel Positive Airway Pressure (Bi-Pap) is an electronic breathing device used in the treatment of sleep apnoea, lung disease, and to treat respiratory weakness in ALS. Use of the device overnight improves quality of sleep, daytime sleepiness, and may improve thinking ability.
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| ALS (Amyotrophic Lateral Sclerosis) | 7 | 1 |
|
||||
| Breathing difficulty | 6 | 0 | |||||
| Fatigue | 2 | 0 | |||||
| Decreased respiratory function | 1 | 0 | |||||
| Decreased diaphragm strength | 1 | 0 | |||||
| Support quality of life | 1 | 0 | |||||
See all 11 patients currently using Trilogy 100
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Trilogy 100
| Dry mouth (xerostomia) | 1 | |
|---|---|---|
| Dry throat | 1 | |
| sore nose where the mask rests | 1 |
Reported Schedules
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Trilogy 100
Always |
1 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Trilogy 100
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 100% |
|
A little |
0 | 0% |
|
Not at all |
0 | 0% |
|
Cost
Paid out of pocket
Cost of Trilogy 100
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
0 | 0% |
|